EX-4.3 8 d312753dex43.htm EX-4.3 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406. Voices Against Brain Cancer Research and Development...Research and Development Grant Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionThis Agreement, dated June 5, 2013, by and between Tocagen Inc. (“Tocagen”), a Delaware corporation with an address at 3030 Bunker Hill Street, Suite 230, San Diego, CA 92109 and Voices Against Brain Cancer (“VABC”) a non-profit corporation with an address at Voices Against Brain Cancer 1375 Broadway, 3rd Floor, New York, NY 10018.
Voices Against Brain Cancer Research and Development Grant Agreement for Tocagen Inc.Research and Development Grant Agreement • March 9th, 2017 • Tocagen Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Agreement, dated June 5, 2013, by and between Tocagen Inc. (“Tocagen”), a Delaware corporation with an address at 3030 Bunker Hill Street, Suite 230, San Diego, CA 92109 and Voices Against Brain Cancer (“VABC”) a non-profit corporation with an address at Voices Against Brain Cancer 1375 Broadway, 3rd Floor, New York, NY 10018.
Voices Against Brain Cancer Research and Development Grant Agreement for Tocagen Inc.Research and Development Grant Agreement • October 23rd, 2015 • Tocagen Inc • Pharmaceutical preparations • California
Contract Type FiledOctober 23rd, 2015 Company Industry JurisdictionThis Agreement, dated June 5, 2013, by and between Tocagen Inc. (“Tocagen”), a Delaware corporation with an address at 3030 Bunker Hill Street, Suite 230, San Diego, CA 92109 and Voices Against Brain Cancer (“VABC”) a non-profit corporation with an address at Voices Against Brain Cancer 1375 Broadway, 3rd Floor, New York, NY 10018.